pixantrone has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gallagher, CE; Getahun, Z; Giuliani, FC; Hacker, MP; Krapcho, AP; Landi, JJ; Maresch, MJ; Petry, ME; Polsenberg, JF; Stallman, J | 1 |
1 other study(ies) available for pixantrone and Colonic Neoplasms
Article | Year |
---|---|
6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Topics: Adenocarcinoma; Animals; Anthraquinones; Antineoplastic Agents; Colonic Neoplasms; Humans; Isoquinolines; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA; Mitoxantrone; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |